Daffy

Aeras Global Tb Vaccine Foundation

Aeras Global Tb Vaccine Foundation

Germantown, MD 20875
Tax ID52-2044704

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Aeras Global Tb Vaccine Foundation? Learn more here.

About this organization

Revenue

$11,652,936

Expenses

$24,169,942

Website

aeras.org

Mission

Aeras Is A Non-Profit Product Development Organization Dedicated To The Development Of Effective Tuberculosis (Tb) Vaccines And Biologics To Prevent Tb Across All Age Groups In An Affordable And Sustainable Manner. Aeras Utilizes Its Broad Capabilities And Technologies In Collaboration With Numerous Partners And Stakeholders To Support The Development Of Vaccines And Other Biopharmaceuticals To Address Tb And Other Significant Public Health Needs Of Underserved Populations. In The Pursuit Of Our Mission, We Are Guided By Our Core Values. These Core Values Express Our Aspirations And The Behaviors We Want To Exhibit And Model. They Shape The Culture And Character Of Aeras And Inform All Of Our Decisions And Actions.

About

PRECLINICAL - AERAS DEVELOPS AND ASSESSES A RANGE OF VACCINE PLATFORMS AND VARIATIONS, AND EXPLORES NOVEL APPROACHES TO ENHANCE THE EFFECTIVENESS OF NEW TB VACCINES IN EFFECTIVE PRIME-BOOST REGIMENS. AERAS EVALUATES TB VACCINE CANDIDATES TO DETERMINE WHETHER THEY HAVE THE CHARACTERISTICS NEEDED TO MOVE FORWARD TO THE NEXT PHASE OF DEVELOPMENT. KEY ELEMENTS INCLUDE EVALUATION OF SAFETY, IMMUNOGENICITY AND THE PROTECTION THE CANDIDATES PROVIDE IN ANIMAL MODELS. AN INDEPENDENT PANEL OF VACCINE EXPERTS EVALUATES ALL RELEVANT PRECLINICAL DATA BEFORE A CANDIDATE IS APPROVED FOR ENTRY INTO PHASE I TRIALS. AERAS ALSO SUPPORTS THE ASSESSMENT OF NOVEL ASSAYS THAT COULD BE IMPLEMENTED AT THE CLINICAL STAGE OF DEVELOPMENT TO DRASTICALLY REDUCE THE TIME AND COST OF DEVELOPING NEW VACCINES AGAINST TUBERCULOSIS.

Interesting data from their 2019 990 filing

The purpose of the non-profit is stated in the filing as “Aeras is a non-profit product development organization dedicated to the development of effective tuberculosis (tb) vaccines and biologics to prevent tb across all age groups in an affordable and sustainable manner. aeras utilizes its broad capabilities and technologies in collaboration with numerous partners and stakeholders to support the development of vaccines and other biopharmaceuticals to address tb and other significant public health needs of underserved populations. in the pursuit of our mission, we are guided by our core values. these core values express our aspirations and the behaviors we want to exhibit and model. they shape the culture and character of aeras and inform all of our decisions and actions.”.

Their activities were defined as: “Dedicated to the development of effective tuberculosis (tb) vaccines & biologics to prevent tb across all age groups in an affordable & sustainable manner.”.

  • As per legal requirements, the non-profit's state of operation is reported as DC.
  • The non-profit's address in 2019 as per the filing is PO BOX 20875, Germantown, MD, 20875.
  • The form of the non-profit organization shows 47 employees as of 2019.
  • Does not operate a hospital.
  • Does not operate a school.
  • Does not collect art.
  • Does not provide credit counseling.
  • Has foreign activities.
  • Is not a donor advised fund.
  • Is not a private foundation.
  • Expenses are greater than $1,000,000.
  • Revenue is greater than $1,000,000.
  • Revenue less expenses is -$12,517,006.
  • The compensation policy for the CEO of the organization is established through an impartial evaluation and endorsement.
  • The organization has a written policy that describes how long it will retain documents.
  • The organization has a foreign financial account.
  • The organization has 10 independent voting members.
  • The organization was formed in 1997.
  • The organization has a written policy that addresses conflicts of interest.
  • The organization is required to file Schedule B.
  • The organization is required to file Schedule J.
  • The organization is required to file Schedule O.
  • The organization pays $7,880,320 in salary, compensation, and benefits to its employees.
  • The organization pays $0 in fundraising expenses.
  • The organization provides Form 990 to its governing body.
  • The organization has minutes of its meetings.
  • The organization has a written whistleblower policy.
  • The organization has grants to organizations.
  • The organization's financial statements were reviewed by an accountant.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.